Save your place

Sign in to WhoBought

Please try again later.

MiNK Therapeutics, Inc. (INKT) institutional ownership

Latest close $11.07 Jul 21, 2026
Market cap$59M 52-week range SectorHealthcare
Funds holding · Q1 2026
15
reported INKT position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
5 buyers · 10 sellers

MiNK Therapeutics, Inc. (INKT) price and institutional activity

Dates

Q1 2026

$0 bought by 5 investors
UBS Group AGGeode +3 more
$0 sold by 10 investors
Drw Securities, LLCRenaissance Technologies LLC +8 more
Bought Sold Totals per quarter; hover a bar for the names.

MiNK Therapeutics, Inc. (INKT) institutional activity · 15

Investor Type Est. change Change Δ Own Date
Drw Securities, LLC · Exited
Change −26K Δ Own −100.0% Date Q1 2026
Drw Securities, LLC Exited· Q1 2026 −26K −100.0% Q1 2026
Renaissance Technologies LLC Exited· Q1 2026 −10K −100.0% Q1 2026
UBS Group AG · Added
Change +6K Date Q1 2026
UBS Group AG Added· Q1 2026 +6K Q1 2026
Geode · Added
Change +3K Date Q1 2026
Geode Added· Q1 2026 +3K Q1 2026
Steward Partners Investment Advisory, LLC · New
Change +2K Date Q1 2026
Steward Partners Investment Advisory, LLC New· Q1 2026 +2K Q1 2026
Bank of America Corp · Exited
Change −568 Δ Own −100.0% Date Q1 2026
Bank of America Corp Exited· Q1 2026 −568 −100.0% Q1 2026
Citigroup Inc · Reduced
Change −246 Date Q1 2026
Citigroup Inc Reduced· Q1 2026 −246 Q1 2026
Annis Gardner Whiting Capital Advisors, LLC · New
Change +200 Date Q1 2026
Annis Gardner Whiting Capital Advisors, LLC New· Q1 2026 +200 Q1 2026
Horizon Financial Services, LLC · Exited
Change −160 Δ Own −100.0% Date Q1 2026
Horizon Financial Services, LLC Exited· Q1 2026 −160 −100.0% Q1 2026
Tower Research Capital LLC (trc) · Reduced
Change −139 Date Q1 2026
Tower Research Capital LLC (trc) Reduced· Q1 2026 −139 Q1 2026
Osaic Holdings, Inc. · Reduced
Change −116 Date Q1 2026
Osaic Holdings, Inc. Reduced· Q1 2026 −116 Q1 2026
Wells Fargo & Company · Exited
Change −20 Δ Own −100.0% Date Q1 2026
Wells Fargo & Company Exited· Q1 2026 −20 −100.0% Q1 2026
Covestor Ltd · Reduced
Change −12 Date Q1 2026
Covestor Ltd Reduced· Q1 2026 −12 Q1 2026
Caitong International Asset Management Co., Ltd · New
Change +10 Date Q1 2026
Caitong International Asset Management Co., Ltd New· Q1 2026 +10 Q1 2026
Barclays PLC · Exited
Change −4 Δ Own −100.0% Date Q1 2026
Barclays PLC Exited· Q1 2026 −4 −100.0% Q1 2026
Data through Q1 2026 · filed May 15, 2026
15 of 15

Famous investor activity in MiNK Therapeutics, Inc. (INKT)

MiNK Therapeutics, Inc. (INKT) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Ryan Barbara · Director 2 operations −$19K
Price $12.68–$12.80 Qty −2K Owned 22K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Ryan Barbara Director 2 operations $12.68–$12.80 −2K −$19K 22K Jun 4, 2026 Jun 5, 2026
Holcomb John Bradley · Director Grant (A) $14K
Price $12.38 Qty 1K Owned 3K Trade date Jun 1, 2026 Filed date Jun 2, 2026
Holcomb John Bradley Director Grant (A) $12.38 1K $14K 3K Jun 1, 2026 Jun 2, 2026
Ryan Barbara · Director Grant (A) $18K
Price $12.38 Qty 1K Owned 23K Trade date Jun 1, 2026 Filed date Jun 2, 2026
Ryan Barbara Director Grant (A) $12.38 1K $18K 23K Jun 1, 2026 Jun 2, 2026
Corvese Brian · Director Grant (A) $18K
Price $12.38 Qty 1K Owned 53K Trade date Jun 1, 2026 Filed date Jun 2, 2026
Corvese Brian Director Grant (A) $12.38 1K $18K 53K Jun 1, 2026 Jun 2, 2026
Behner Peter · Director Grant (A) $16K
Price $12.38 Qty 1K Owned 23K Trade date Jun 1, 2026 Filed date Jun 2, 2026
Behner Peter Director Grant (A) $12.38 1K $16K 23K Jun 1, 2026 Jun 2, 2026
Wiinberg Ulf · Director Grant (A) $14K
Price $12.38 Qty 1K Owned 23K Trade date Jun 1, 2026 Filed date Jun 2, 2026
Wiinberg Ulf Director Grant (A) $12.38 1K $14K 23K Jun 1, 2026 Jun 2, 2026
Ryan Barbara · Director 3 operations −$20K
Price $15.28–$15.57 Qty −1K Owned 21K Trade date Mar 10, 2026 Filed date Mar 11, 2026
Ryan Barbara Director 3 operations $15.28–$15.57 −1K −$20K 21K Mar 10, 2026 Mar 11, 2026
Ryan Barbara · Director Sell −$2K
Price $10.17 Qty −200 Owned 22K Trade date Mar 9, 2026 Filed date Mar 11, 2026
Ryan Barbara Director Sell $10.17 −200 −$2K 22K Mar 9, 2026 Mar 11, 2026
Holcomb John Bradley · Director Grant (A) $14K
Price $10.90 Qty 1K Owned 2K Trade date Mar 2, 2026 Filed date Jun 2, 2026
Holcomb John Bradley Director Grant (A) $10.90 1K $14K 2K Mar 2, 2026 Jun 2, 2026
Ryan Barbara · Director Grant (A) $18K
Price $10.90 Qty 2K Owned 22K Trade date Mar 2, 2026 Filed date Jun 2, 2026
Ryan Barbara Director Grant (A) $10.90 2K $18K 22K Mar 2, 2026 Jun 2, 2026
Corvese Brian · Director Grant (A) $18K
Price $10.90 Qty 2K Owned 52K Trade date Mar 2, 2026 Filed date Jun 2, 2026
Corvese Brian Director Grant (A) $10.90 2K $18K 52K Mar 2, 2026 Jun 2, 2026
Behner Peter · Director Grant (A) $16K
Price $10.90 Qty 1K Owned 22K Trade date Mar 2, 2026 Filed date Jun 2, 2026
Behner Peter Director Grant (A) $10.90 1K $16K 22K Mar 2, 2026 Jun 2, 2026
Wiinberg Ulf · Director Grant (A) $14K
Price $10.90 Qty 1K Owned 22K Trade date Mar 2, 2026 Filed date Jun 2, 2026
Wiinberg Ulf Director Grant (A) $10.90 1K $14K 22K Mar 2, 2026 Jun 2, 2026
Ryan Barbara · Director Sell −$1K
Price $10.83 Qty −100 Owned 22K Trade date Mar 2, 2026 Filed date Mar 4, 2026
Ryan Barbara Director Sell $10.83 −100 −$1K 22K Mar 2, 2026 Mar 4, 2026
Ryan Barbara · Director Sell −$4K
Price $10.86 Qty −400 Owned 22K Trade date Feb 27, 2026 Filed date Mar 4, 2026
Ryan Barbara Director Sell $10.86 −400 −$4K 22K Feb 27, 2026 Mar 4, 2026
15 of 38
15 of 38 Sign in to continue to older insider transactions.

MiNK Therapeutics, Inc. (INKT) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Agenus Inc 21.5M
% of shares outstanding 62.5% Filing date May 26, 2023
Agenus Inc 21.5M 62.5% May 26, 2023
1 of 1

MiNK Therapeutics, Inc. (INKT) ownership FAQ

Who owns INKT?

15 reporting institutions disclosed INKT position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.